Detalhe da pesquisa
1.
HLA-DRB1*1501 influences long-term disability progression and tissue damage on MRI in relapse-onset multiple sclerosis.
Mult Scler
; 29(3): 333-342, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36398585
2.
Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations.
Mult Scler
; 28(14): 2177-2189, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36000489
3.
Longitudinal Assessment of Multiple Sclerosis with the Brain-Age Paradigm.
Ann Neurol
; 88(1): 93-105, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32285956
4.
Longitudinal spinal cord atrophy in multiple sclerosis using the generalized boundary shift integral.
Ann Neurol
; 86(5): 704-713, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31385358
5.
Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
Brain
; 142(8): 2276-2287, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31342055
6.
A practical approach to assessing and managing sexual dysfunction in multiple sclerosis.
Pract Neurol
; 20(2): 122-131, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31753860
7.
Deep gray matter volume loss drives disability worsening in multiple sclerosis.
Ann Neurol
; 83(2): 210-222, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29331092
8.
Cortical grey matter sodium accumulation is associated with disability and secondary progressive disease course in relapse-onset multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 90(7): 755-760, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30948625
9.
Progression of regional grey matter atrophy in multiple sclerosis.
Brain
; 141(6): 1665-1677, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29741648
10.
Diagnosis of multiple sclerosis: progress and challenges.
Lancet
; 389(10076): 1336-1346, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27889190
11.
An abnormal periventricular magnetization transfer ratio gradient occurs early in multiple sclerosis.
Brain
; 140(2): 387-398, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28043954
12.
Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide study.
J Neurol Neurosurg Psychiatry
; 2022 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35273069
13.
Incidence and prevalence of NMOSD in Australia and New Zealand.
J Neurol Neurosurg Psychiatry
; 88(8): 632-638, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28550069
14.
Cladribine-induced liver injury: Implications for practice.
Mult Scler
; 28(13): 2146, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36169282
15.
Periventricular lesions and MS diagnostic criteria in young adults with typical clinically isolated syndromes.
Mult Scler
; 23(7): 1031-1034, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27600111
16.
Misdiagnosis of multiple sclerosis: Time for action.
Mult Scler
; 27(6): 805-806, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33949226
17.
Neurology in the time of COVID-19.
J Neurol Neurosurg Psychiatry
; 91(6): 568-570, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32312872
18.
COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual?
Mult Scler
; 26(10): 1267, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32762499
19.
Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 90(12): 1376-1378, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31079064
20.
Instead of tweaking the diagnostic criteria for MS in those with CIS, we should develop diagnostic criteria that distinguish MS from other conditions - No.
Mult Scler
; 25(6): 768-770, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30632420